For the Quarter Ending September 2025
North America
• In USA, the Potassium Iodide Price Index rose by 2.80% quarter-over-quarter, reflecting supply chain tightening.
• The average Potassium Iodide price for the quarter was approximately USD 64077.33/MT reported by distributors.
• Potassium Iodide Spot Price firmed as Asian availability tightened, strengthening landed import offers and buyer urgency.
• Potassium Iodide Price Forecast signals moderate gains as restocking continues and inventory levels gradually normalize.
• Potassium Iodide Production Cost Trend rose as feedstock and freight expenses increased, compressing supplier margins.
• Potassium Iodide Demand Outlook remains constructive from pharmaceutical, API, personal care sectors supporting sustained offtake.
• Potassium Iodide Price Index movements reflected restocking, inventory draws and stronger domestic manufacturing activity during quarter.
• Export demand and logistics resilience constrained offers, tightening short term availability and commercial market discipline.
Why did the price of Potassium Iodide change in September 2025 in North America?
• Reduced Asian export offers earlier in quarter increased availability and encouraged aggressive distributor pricing discipline.
• Higher import costs, freight dynamics, and currency shifts tightened landed margins supporting elevated seller offers.
• Inventory draws from restocking and stronger pharmaceutical demand improved market tone sustaining upward momentum.
APAC
• In China, the Potassium Iodide Price Index rose by 2.8% quarter-over-quarter, driven by tighter inventories.
• The average Potassium Iodide price for the quarter was approximately USD 63933.33/MT during Q3 2025.
• Potassium Iodide Spot Price stayed volatile amid feedstock swings, mirroring a declining Production Cost Trend.
• The Potassium Iodide Price Forecast shows modest upside risk from restocking and firmer overseas inquiries.
• Potassium Iodide Demand Outlook reflects strong pharmaceutical offtake partially offsetting weaker general export orders abroad.
• Potassium Iodide Price Index movements balanced earlier stockbuilding with recent planned production slowdowns and adjustments.
• Easing freight rates and improving export demand tightened physical availability, supporting Potassium Iodide price resilience.
• Major producers' planned maintenance reduced immediate output, temporarily tightening supply and lifting the Price Index.
Why did the price of Potassium Iodide change in September 2025 in APAC?
• Elevated inventories in the quarter pressured exporters, reducing shipments and softening Potassium Iodide quotations globally.
• Rising feedstock costs and production adjustments squeezed margins, prompting pricing revisions and altering supply rhythms.
• Logistics changes and freight rate shifts raised landed costs, moderating overseas buying and export flows.
Europe
• In Germany, the Potassium Iodide Price Index rose by 3.70% quarter-over-quarter, reflecting inventory adjustments and mixed import dynamics.
• The average Potassium Iodide price for the quarter was approximately USD 67499.00/MT, reported across German market channels during Q3 2025.
• Potassium Iodide Spot Price softened as Asian exporters lowered offers and distributors prioritized inventory clearance over purchases.
• Potassium Iodide Price Forecast indicates modest upside later as inventory drawdowns combine with cautiously improving downstream orders.
• Potassium Iodide Production Cost Trend remained subdued due to lower feedstock import costs yet pressured by higher freight rates.
• Potassium Iodide Demand Outlook shows gradual restocking from pharmaceuticals, offset by cautious buying and ample distributor inventories restraining gains.
• Potassium Iodide Price Index volatility moderated as balanced imports and steady domestic shipments reduced short-term price spikes.
• Export demand remained mixed; German suppliers trimmed offers to clear stock while end-users delayed large-scale procurement.
Why did the price of Potassium Iodide change in September 2025 in Europe?
• Ample inventories from imports and domestic stocks reduced urgency for purchases, weighing on landed prices.
• Lower Asian export offers and favourable Euro exchange rates decreased import costs, pressuring market quotations.
• Rising freight rates and cautious downstream demand limited restocking, constraining upward price movement during September.
MEA
• In the United Arab Emirates, the Potassium Iodide Price Index rose by 3.61% quarter-over-quarter, reflecting restocking.
• The average Potassium Iodide price for the quarter was approximately USD 67408.00/MT, reflecting import dynamics.
• Low importer stocks and weaker orders pressured the Potassium Iodide Spot Price despite firm offers.
• Export flows and freight increases raised landed costs, pushing the Potassium Iodide Production Cost Trend.
• Analysts expect a gradual Potassium Iodide Price Forecast normalization as inventories tighten and procurement stabilizes.
• Pharmaceutical demand recovery supports the Potassium Iodide Demand Outlook while importers cautiously resume strategic restocking.
• Export variability and supplier destocking moderated the Potassium Iodide Price Index across regional wholesale networks.
• Operational tightness at key Asian exporters tightened availability, supporting temporary upward pressure on local pricing.
Why did the price of Potassium Iodide change in September 2025 in MEA?
• Elevated importer restocking and reduced regional inventories tightened supply, prompting modest upward pressure on prices.
• Higher export offers and freight normalization raised landed costs, exerting upward influence on procurement valuations.
• Stable downstream demand from pharmaceuticals offset earlier weakness, supporting sustainable offtake and limiting price declines.
For the Quarter Ending June 2025
North America
• Price Index for Potassium Iodide in North America showed a continued downward trend in July 2025, extending the sharp 14.89% decline witnessed in June as weak fundamentals persisted into the new month.
• Spot Price in July 2025 for Potassium Iodide 99% CFR New York dropped further from USD 56,618/MT recorded in June, reflecting ongoing market softness and poor demand from pharmaceutical and healthcare sectors.
• In April, Potassium Iodide prices surged due to rising Chinese export prices, tight inventories, and increased consumption across U.S. pharmaceutical and radioprotection markets. Trade uncertainties and a depreciating U.S. dollar added to procurement costs.
• In May, the upward trend continued amid stronger demand and higher import prices following Chinese tariff concessions. Restocking activity increased, while the USD depreciation kept import costs elevated, pushing prices higher.
• In June, prices declined sharply as inventory levels across the U.S. remained high, and Chinese exporters slashed prices to clear excess stock. Reduced import costs and cautious domestic procurement dragged prices down significantly.
• In July, the Production Cost Trend remained flat to slightly weaker due to stabilized feedstock costs in Asia. However, the impact of prior oversupply and aggressive export pricing lingered, continuing to depress U.S. procurement sentiment.
• The Demand Outlook remained soft as healthcare and pharmaceutical segments operated with sufficient inventory. Buyers avoided bulk orders and deferred purchases, awaiting clearer pricing signals or inventory depletion.
• Export Competitiveness of Potassium Iodide from Asia remained strong, particularly from China, where suppliers continued to offer discounted quotes. This kept pressure on domestic sellers in the U.S., who struggled to match imported cost advantages.
• Inventory Dynamics showed no significant drawdown in July. Distributors and end users held adequate stock, which curbed immediate purchasing needs and sustained downward pressure on prices.
• Why did the price change in July 2025?
The price fell due to persistent oversupply, low restocking activity, and subdued demand from core downstream sectors. Combined with low import prices from China, U.S. buyers maintained a conservative stance, pushing prices further down.
• Price Forecast (August 2025):
Potassium Iodide prices in the U.S. are expected to remain weak or stabilize slightly in August unless significant restocking occurs or supply tightens. With inventories still high, upside momentum will likely be capped without a demand rebound.
Europe
• Potassium Iodide 99% CFR Hamburg (Germany) Spot Price averaged USD 61,780/MT in June 2025, reflecting a steep 8.54% decline from May levels. In July 2025, prices fell further to USD 59,100/MT, registering a 4.34% month-on-month decrease, amid continued inventory surplus and weak procurement activity.
• The Price Index for Potassium Iodide in Germany continued on a downward trajectory in July, driven by ample supply availability, weak restocking sentiment, and aggressive price undercutting from overseas exporters.
• The Price Forecast for August 2025 indicates potential further softening in prices unless demand from core sectors like pharmaceuticals improves. Without a recovery in offtake, CFR Hamburg values are expected to trend below USD 59,000/MT.
• Production Cost Trend remained steady, but the strong Euro helped mitigate import-related expenses. However, higher freight rates from Asia offset some currency-related gains, limiting margin flexibility for importers.
• Demand Outlook in July remained lackluster, with subdued order flow from pharmaceutical and radioprotection segments. Distributors and end-users continued to rely on existing inventories, further weakening buying interest.
• Why did the price of Potassium Iodide change in July 2025? The decline to USD 59,100/MT was due to sustained excess supply, lower offshore offers from Indian and Chinese exporters, soft downstream demand, and limited restocking appetite in Germany.
• Inventory levels remained high across Germany, prompting a deferral in bulk orders. Buyers showed preference for short-term, small-volume procurement, anticipating further discounts amid competitive global supply conditions.
• Export competitiveness of Indian and Chinese Potassium Iodide remained strong in July, with lower FOB prices pressuring German importers and domestic sellers to reduce their offers to remain viable in a saturated market.
• Freight costs from Asia to Europe stayed elevated in July, straining import margins. However, the favorable EUR/USD exchange rate absorbed part of the logistics cost hike, keeping landed costs relatively stable despite reduced selling prices.
• Overall, unless there is a significant drawdown in inventories or a revival in end-user demand, German Potassium Iodide prices are expected to stay under pressure heading into August 2025.
APAC
• Price Index for Potassium Iodide 99% in China continued its downward trajectory in July 2025, with FOB Shanghai prices dropping from USD 56430 in June to lower levels, reflecting a month-on-month decline.
• Spot Price correction was driven by continued oversupply and limited downstream offtake. The inventory overhang from previous months led producers to reduce quotations further to clear excess stock.
• In July 2025, prices declined due to sluggish export demand, weak restocking activity across international markets, and currency strength of the Chinese Yuan, which reduced China’s export competitiveness. Simultaneously, freight rate hikes limited foreign procurement appetite.
• Production Cost Trend remained soft for the fifth consecutive month due to steady declines in input material costs, especially Caustic Potash. With feedstock prices under pressure, manufacturers faced reduced cost-push inflation.
• Demand Outlook for July stayed weak in both domestic and international markets. The pharmaceutical sector maintained a cautious procurement strategy due to ample inventory, while healthcare procurement slowed in Southeast Asian and Middle Eastern markets.
• Why did the price of Potassium Iodide change in July 2025?
Prices declined sharply due to weak overseas orders, high supplier-side inventories, falling input costs, and reduced urgency for restocking from both global and domestic buyers. The strengthening Yuan further hurt the export outlook, adding pressure on Chinese exporters to reduce FOB prices.
MEA
• Price Index for Potassium Iodide 99% in the UAE continued its downward momentum in July 2025, following a sharp 8.58% decline in June. CFR Jebel Ali prices dropped further from USD 61,729/MT in June to lower levels in July, reflecting prolonged bearish sentiment.
• Spot Price softened further in July as sluggish demand conditions persisted. The continued downturn in regional consumption, especially across pharmaceutical and healthcare sectors, curtailed fresh buying. Importers delayed purchases amid expectations of additional price reductions.
• In July 2025, Potassium Iodide prices declined primarily due to surplus inventories, poor offtake, and ongoing geopolitical uncertainties in the Middle East. The spillover effects of June’s high inventory buildup were still visible in the market, keeping stock levels elevated and dampening procurement enthusiasm.
• Production Cost Trend remained subdued as Indian and Chinese suppliers maintained low export quotations, reflecting falling input costs and ample global availability. The easing of Caustic Potash prices and stable energy costs helped compress upstream price pressures.
• Demand Outlook stayed weak for the second straight month. Despite relatively stable domestic business activity, the pharmaceutical and preventive healthcare sectors reported muted restocking. Higher logistics costs and security concerns around Middle East maritime trade further disincentivized urgent import decisions.
• Why did the price of Potassium Iodide change in July 2025?
The continued price decline was driven by persistently low downstream demand, elevated inventory levels, and soft international pricing trends. A cautious procurement approach by UAE buyers, combined with ongoing geopolitical instability and costlier freight, reinforced the bearish market sentiment and kept CFR prices under pressure.
For the Quarter Ending March 2025
North America
Throughout Q1 2025, Potassium Iodide prices in the U.S. exhibited dynamic movement, marked by early gains in January and February followed by a modest correction in March. In January, prices climbed amid strong pharmaceutical demand and tight supply conditions. Logistics bottlenecks, particularly at the Port of Los Angeles, coupled with rising freight rates and labor shortages, extended lead times and increased import costs. These disruptions amplified market volatility, encouraging proactive inventory strategies that supported upward price momentum.
In February, the uptrend persisted, reinforced by higher production costs and the implementation of a 10% tariff on Chinese imports. The U.S. market, heavily dependent on Asian suppliers, faced elevated procurement expenses due to both costlier raw materials and export price hikes from China. Although logistical costs eased slightly, continued tight supply and rising industrial demand sustained pricing pressure. A rebound in U.S. manufacturing activity and growing buyer interest, partly driven by regulatory uncertainty, added to the bullish sentiment.
However, March saw a reversal as ample inventories and lower landed costs softened market conditions. Falling freight rates and discounting by global suppliers improved supply availability, easing price pressure. At the same time, declining industrial activity and subdued consumer spending weighed on demand, prompting cautious purchasing behavior and contributing to a marginal price decline across the U.S. Potassium Iodide market.
Asia Pacific
In Q1 2025, Potassium Iodide prices in China experienced a fluctuating trend shaped by evolving supply conditions, trade policy shifts, and shifting demand from domestic and international markets. January began with a price rebound, following aggressive destocking at the end of 2024. International buyers, particularly from the U.S., accelerated procurement to preempt potential tariff escalations, driving stronger export demand. At the same time, rising freight rates, logistical delays following the Lunar New Year, and increasing raw material costs prompted Chinese suppliers to recalibrate prices upward amid seasonal production slowdowns.
In February, the uptrend continued as Potassium Iodide prices rose by 0.61%. Supply remained constrained due to lower inventories and heightened demand from the pharmaceutical and nutraceutical sectors. The 10% U.S. tariff on Chinese imports compounded pricing pressure, alongside rising input costs and trade policy uncertainties. Although China’s PMI pointed to a recovery in factory activity, tight inventories and global logistics bottlenecks kept the market firm, reinforcing inflationary trends across both domestic and export segments.
However, by March, the market shifted toward a softer pricing environment. Elevated production activity led to inventory build-up, while weaker domestic consumption and subdued export demand—exacerbated by rising unemployment and U.S. trade tensions—curtailed market momentum. With stock levels outpacing offtake, sellers resorted to competitive discounting, resulting in a modest price decline by the end of the quarter..
Europe
The Potassium Iodide market in Germany experienced varying price movements across Q1 2025, shaped by shifting demand trends, fluctuating import costs, and broader macroeconomic influences. In January, prices rose modestly as German buyers accelerated procurement in anticipation of potential supply disruptions from Asia during the Lunar New Year. Strategic inventory buildup by food preservative and industrial users supported pricing momentum, though ample inventories helped keep the market balanced and prevented sharp surges.
February saw a reversal, with prices declining amid elevated stock levels and soft downstream demand. Weakened purchasing activity from the pharmaceutical and food sectors, alongside aggressive destocking, contributed to bearish sentiment. Lower freight rates from China also eased cost pressures, while the depreciation of the euro increased import-related expenses, prompting a cautious, need-based procurement strategy among buyers. Despite stable manufacturing output, demand contraction persisted due to inflationary headwinds and subdued industrial recovery.
In contrast, March marked a sharp rebound in prices. Rising export offers from India, driven by higher input costs, raised import values across Europe. Domestically, improved industrial indicators and consistent demand from the healthcare sector underpinned firm market fundamentals. Although shipping costs from Asia eased slightly, currency depreciation and higher procurement costs outweighed logistical relief. These combined factors sustained upward pricing pressure, ending the quarter with a firm pricing trajectory.
MEA
In the UAE, Potassium Iodide prices fluctuated throughout Q1 2025, shaped by a mix of proactive procurement strategies, external cost pressures, and evolving downstream dynamics. January opened with a notable price surge as buyers accelerated purchases ahead of the Lunar New Year, anticipating potential delays from key Asian suppliers. Food-grade and industrial users took strategic positions to secure inventory, ensuring market stability amid steady demand and uninterrupted supply from Asia.
By February, the market saw a downturn in prices, primarily due to elevated stock levels and a drop in Indian import offers. Ongoing destocking efforts, coupled with weak offtake from the pharmaceutical and food sectors, led to a subdued demand environment. Despite stable manufacturing and efficient logistics through major UAE ports, the influx of competitively priced Asian imports and cautious buyer behavior intensified downward pressure on prices.
March brought a sharp rebound, driven by higher Indian export offers following increased raw material input costs. While industrial sentiment dipped slightly, consistent new orders sustained import demand. Domestic consumption remained steady, particularly in pharmaceutical applications. Though freight rates declined marginally, they failed to offset the broader rise in procurement and currency-related costs. As a result, upward pricing momentum was restored, ending the quarter with a firm market tone.
For the Quarter Ending December 2024
North America
The overall trend for Q4 2024 in the U.S. Potassium Iodide market has been characterized by fluctuating prices, with significant volatility driven by supply chain disruptions, import cost increases, and seasonal demand shifts. In October, prices surged due to heightened seasonal demand from food and beverage sectors, combined with elevated shipping costs and supply chain constraints. The rising fuel costs limited domestic production, and port congestion further contributed to price hikes. Strategic stockpiling by suppliers in anticipation of winter demand amplified pressures on available inventories.
November saw continued price escalation, driven by strong export demand and import challenges, especially from China. While port congestion and high procurement costs persisted, the market remained pressured by uncertainties, including potential tariff changes.
In December, prices fell due to weak demand from key sectors like pharmaceuticals, coupled with substantial inventories and oversupply. Intense competition from Asian imports and domestic destocking efforts exerted downward pressure on prices. Despite stable production levels, the subdued export market and lackluster trading activity in downstream industries highlighted a pessimistic market outlook.
Asia Pacific
The Potassium Iodide market in China during Q4 2024 displayed significant volatility, with prices surging in October due to supply constraints, typhoon disruptions, and robust demand. Shipping delays and increased freight costs intensified market pressure, particularly as buyers ramped up procurement ahead of the holiday season.
The pharmaceutical sector’s growing demand further strained supply. In November, the market saw continued price hikes, driven by demand from Western markets, though challenges such as transportation bottlenecks persisted. The market was further affected by geopolitical factors, including tariff concerns, causing a market downturn by the end of the year.
December saw fluctuating trends in the Caustic Potash market. Early month weakness was followed by a brief recovery as factories shipped products and downstream restocking occurred. However, resistance to high-priced shipments and ongoing weak demand led to a decline in market activity by month’s end, with factories offering discounts to maintain sales. Overall, Q4 2024 saw a mix of price surges and downturns driven by geopolitical, logistical, and demand factors, with fluctuating market dynamics throughout the quarter.
Europe
The Potassium Iodide market in Germany experienced a mixed trend throughout Q4 2024, initially marked by a steady price increase followed by a pronounced decline. Rising global economic challenges, supply chain disruptions, and limited supply from key producers led to higher prices early in the quarter.
These factors were compounded by increased import costs and a strong demand from certain sectors, allowing domestic sellers to capitalize on arbitrage opportunities. However, by November, the market saw significant price drops, driven by weak demand and excess inventory, particularly after pre-holiday stockpiling. Despite stable supply conditions, traders focused on inventory destocking, exacerbating the bearish sentiment.
Additionally, the depreciation of the Euro and cautious procurement strategies from buyers further pressured prices. The market faced a supply-demand imbalance and high export prices from China, which added to the volatility. Overall, Q4 2024 was characterized by fluctuations between price increases early on, followed by softening trends due to inventory management and a weak demand outlook in the latter months.
